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We present here a comprehensive molecular mapping of
virus-induced autoimmune B cell responses obtained by
SEREX analysis (serological identification of recom-
binantly expressed antigens). Immunoscreening of cDNA
expression libraries of various organs (lung, liver, and
spleen) using sera from mice infected with cytopathic
(vaccinia virus, VV) or non-cytopathic (lymphocytic chor-
iomeningitis virus, LCMV) viruses revealed a broad specif-
icity of the elicited autoantibody response. Interestingly,
the majority of the identified autoantigens have been pre-
viously described as autoantigens in humans. We found
that induction of virus-induced autoantibodies of the IgG
class largely depends on the CD40-CD40L-mediated
interaction between T and B cells. Furthermore, antibody
titers against a number of autoantigens were comparable
to the concomitantly induced antiviral antibody response.
Comparison of serum reactivity against a selected panel of
autoantigens after infection with VV, LCMV or vesicular
stomatitis virus showed that the different virus infections
triggered distinct autoantibody responses suggesting that
virus infections may leave specific "autoantibody finger-
prints" in the infected host.
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